PTC Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: PTC Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: PTC Therapeutics Inc
Rating: 2.44841675
Author: Trendlyne DVM scores

about

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that in...

49.33 -0.46 (-0.92%)

62.22% Gain from 52W Low

906.9K

XNAS Volume

XNAS 29 Aug, 2025 5:30 PM (EDT)

Board Meeting

The next board meeting for PTC Therapeutics Inc is on 08 Sep 2025 for the purpose of Morgan Stanley 23rd Annual Global Healthcare Conference See details

Not Eligible

Mid Valuation

38.7 / 100

Technically Neutral

59.3 / 100

1Yr Price target upside is 35%

16 analysts

PTC Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

PTC Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that in...

62.22% Gain from 52W Low

SWOT Analysis

PTC Therapeutics Inc Live Price Chart